Swedish Orphan Biovitrum AB (PK) (BIOVF)
USOTC
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
Total Revenue | 5.2B | 6.51B | 9.14B | 14.25B | 15.26B | 15.53B | 18.79B | 22.12B |
Operating Income | 1.1B | 1.65B | 3.12B | 4.53B | 4.83B | 3.79B | 3.85B | 4.18B |
Pre Tax Income | 1.05B | 1.53B | 3.08B | 4.25B | 4.22B | 3.3B | 3.32B | 2.95B |
Net Income | 809.07M | 1.15B | 2.42B | 3.3B | 3.25B | 2.68B | 2.64B | 2.41B |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 2.992 | 4.215 | 8.846 | 11.014 | 10.681 | 8.723 | 8.515 | 7.09 |
EBIT | 1.1B | 1.65B | 3.12B | 4.52B | 4.83B | 3.73B | 3.85B | 4.18B |
EBITDA | 1.54B | 2.13B | 3.61B | 6.12B | 6.85B | 5.79B | 6.27B | 7.41B |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.